Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users Who Are Carriers of Hered Prothrombotic Cond
BMJ 316:589-592, deBruijn,S.F.T.M.,et al, 1998
Cerebrovasc Dis Risk Factors:Neuroradiol Findings in Pts with Activated Protein C Resistance
Radiology 207:85-89, Provenzale,J.M.,et al, 1998
High Risk of Cerebral-Vein Thromb in Carriers of Prothrombin-Gene Mutation & Users of Oral Contracept
NEJM 338:1793-1797, 18401998., Martinelli,I.,et al, 1998
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
Elevated Tissue Plasminogen Activator Antigen and Stroke Risk,The Stroke Prevention in Young Women Study
Stroke 30:7-11, Macko,R.F.,et al, 1999
Retinocochleocerebral Vasculopathy
Medicine 77:12-40, Petty,G.W.,et al, 1998
Susac Syndrome
Medicine 77:3-11, Papo,T.,et al, 1998
Protein S Deficiency in Middle-Aged Women with Stroke
Neurol 42:1029-1033, Green,D.,et al, 1992